| Whole-genome sequencing analysis reveals high specificity of CRISPR/Cas9 and TALEN-based genome editing in human iPSCs C Smith, A Gore, W Yan, L Abalde-Atristain, Z Li, C He, Y Wang, ... Cell stem cell 15 (1), 12-13, 2014 | 428 | 2014 |
| Efficient and allele-specific genome editing of disease loci in human iPSCs C Smith, L Abalde-Atristain, C He, BR Brodsky, EM Braunstein, ... Molecular Therapy 23 (3), 570-577, 2015 | 235 | 2015 |
| Xenografts in zebrafish embryos as a rapid functional assay for breast cancer stem-like cell identification A Eguiara, O Holgado, I Beloqui, L Abalde, Y Sanchez, C Callol, ... Cell cycle 10 (21), 3751-3757, 2011 | 72 | 2011 |
| A homozygous ATAD1 mutation impairs postsynaptic AMPA receptor trafficking and causes a lethal encephalopathy J Piard, GKE Umanah, FL Harms, L Abalde-Atristain, D Amram, M Chang, ... Brain 141 (3), 651-661, 2018 | 58 | 2018 |
| Defects in mRNA Translation in LRRK2-Mutant hiPSC-Derived Dopaminergic Neurons Lead to Dysregulated Calcium Homeostasis JW Kim, X Yin, A Jhaldiyal, MR Khan, I Martin, Z Xie, T Perez-Rosello, ... Cell stem cell 27 (4), 633-645. e7, 2020 | 41 | 2020 |
| Abberant protein synthesis in G2019S LRRK2 Drosophila Parkinson disease-related phenotypes I Martin, L Abalde-Atristain, JW Kim, TM Dawson, VL Dawson Fly 8 (3), 165-169, 2014 | 26 | 2014 |
| Dietary Amino Acids Impact LRRK2-Induced Neurodegeneration in Parkinson's Disease Models VG Chittoor-Vinod, S Villalobos-Cantor, H Roshak, K Shea, ... Journal of Neuroscience 40 (32), 6234-6249, 2020 | 17 | 2020 |
| AMPA Receptor Surface Expression Is Regulated by S-Nitrosylation of Thorase and Transnitrosylation of NSF GKE Umanah, M Ghasemi, X Yin, M Chang, JW Kim, J Zhang, E Ma, ... Cell Reports 33 (5), 108329, 2020 | 14 | 2020 |
| AAA+ ATPase Thorase inhibits mTOR signaling through the disassembly of the mTOR complex 1 GKE Umanah, L Abalde-Atristain, MR Khan, J Mitra, MA Dar, M Chang, ... Nature communications 13 (1), 4836, 2022 | 3 | 2022 |
| protein translation in Parkinson’s disease JW Kim, L Abalde-Atristain, H Jia, I Martin, TM Dawson, VL Dawson Parkinson's Disease, 281-309, 2017 | 3 | 2017 |
| Unplugging brain tumor cells L Abalde-Atristain Science Translational Medicine 11 (513), eaaz3710, 2019 | 1 | 2019 |
| Neuronal connections killed in cold blood L Abalde-Atristain Science Translational Medicine 11 (481), 2019 | 1 | 2019 |
| Reply: ATAD1 encephalopathy and stiff baby syndrome: a recognizable clinical presentation J Piard, GK Essien Umanah, FL Harms, L Abalde-Atristain, D Amram, ... Brain 141 (6), e50-e50, 2018 | 1 | 2018 |
| Blaming an unusual suspect for endosomal traffic jams in Alzheimer’s disease L Abalde-Atristain Science Translational Medicine 11 (506), eaaz0730, 2019 | | 2019 |
| Live and let die L Abalde-Atristain Science Translational Medicine 11 (499), eaay4741, 2019 | | 2019 |
| GALvanizing Alzheimer’s disease therapy to combat the inflamed brain L Abalde-Atristain Science Translational Medicine 11 (491), eaax8310, 2019 | | 2019 |
| High Efficiency and Specificity of Human Genome Editing by Cas9-gRNA Targeting Disease-Associated Loci in Patient-Specific iPSCs CJ Smith, W Yan, L Abalde-Atristain, C He, Y Wang, Z Ye, L Cheng MOLECULAR THERAPY 22, S16-S16, 2014 | | 2014 |
